Purchase Order 75F40121P00438
Award Date
8/11/21
Potential Completion Date
10/11/21
Potential Value
$132K
Federal Agency
Food and Drug Administration
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $46,287.52 contract is for the provision of Illumina reagent chemistry kits to support the agency's genomic analysis and sequencing activities. This award does not have any set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the provision of chemistry reagent kits. The contract, valued at $49,966.13, does not have a set-aside designation. Illumina has previously provided sequencing systems, reagents, and services to support genomic research and diagnostics for various federal agencies, including the NIH,...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents, for the provision of Illumina reagent (chemistry) kits. The $35,463.30 award has a completion date of September 14, 2022 and falls under the "REAGENT (CHEMISTRY) KITS" major program code. Illumina has previously provided a range of sequencing systems, reagents, and...
The Department of Health and Human Services' Food and Drug Administration awarded a firm fixed-price delivery order contract worth $133,974.57 to Illumina, Inc., a for-profit manufacturer of sequencing and analytical instruments and reagents. This contract is for the provision of reagent kits to support chemistry-related work, without any set-aside designation. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to federal agencies like the NIH, CDC,...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $163,957.25 contract is for the delivery of Illumina's proprietary reagent chemistry kits to support the agency's genomic analysis and research needs. This award is likely part of a larger contracting vehicle, as Illumina has previously provided sequencing instruments,...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a firm fixed price delivery order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $91,450.20 contract is for the delivery of ILLUMINA REAGENT (CHEMISTRY) KITS. Illumina has provided sequencing systems, reagents, and services to support genomic research and diagnostics for various federal agencies, including the NIH, CDC, USDA, and VA. This...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order contract worth $249,735.88 to Illumina, Inc., a manufacturer and provider of genetic and genomic sequencing solutions. The contract is for the provision of reagent chemistry kits, with no set-aside designation. Illumina has a history of supplying sequencing systems, reagents, consumables, and related services to various federal agencies, including the NIH, CDC, USDA, and VA, to...
This firm fixed-price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $114,035.82 award is for reagent kits to support the agency's research and diagnostics needs. Illumina has previously provided a range of sequencing instruments, reagents, and bioinformatics products to federal agencies like the National Institutes of Health,...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the supply of REAGENT (CHEMISTRY) KITS. The $208,133.41 contract has no set-aside designation and the items are intended to support the agency's life science research and molecular diagnostics programs. Illumina has previously received prime federal contracts from agencies like the...
The Department of Health and Human Services Food and Drug Administration awarded a $63,915.84 firm fixed price delivery order to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, for ILLUMINA REAGENT (CHEMISTRY) KITS. The order does not have a set-aside designation and is scheduled for completion by October 31, 2022. Illumina has previously received prime federal contracts from agencies such as the NIH, CDC, USDA, and VA to provide sequencing systems,...